The advisers of US Food and Drug Administration (FDA) gave their nod to CAR-T Immunotherapy for treating different forms of cancers.This therapy genetically engineers the patient’s own immune cells to target the cancerous ones and destroy them.

Reference Link: http://www.nature.com/news/engineered-cell-therapy-for-cancer-gets-thumbs-up-from-fda-advisers-1.22304

Views : 1211

Leave a Reply

Your email address will not be published. Required fields are marked *

We are glad you have chosen to leave a comment. Please keep in mind that comments are moderated according to our comment policy.